Literature DB >> 28359782

In vivo IL-4 prevents allo-antigen driven CD8+ CTL development.

Charles S Via1, Kateryna Soloviova2, Maksym Puliaiev2, Roman Puliav2, Irina Puliaeva2, Suzanne C Morris3, Fred D Finkelman3.   

Abstract

IL-4 has been shown to suppress acute graft vs. host disease (GVHD) in irradiated hosts. Here we evaluated whether IL-4 suppresses acute GVHD in the un-irradiated parent-into-F1 GVHD model with relevance to renal allograft rejection. IL-4 completely suppressed CD8 CTL when administered with donor cells however this effect was lost if its administration was delayed 3days. IL-4 did not inhibit donor CD8+ T cell homing to the host spleen but rather prevented donor CD8+ T cell differentiation into CTLs. Studies with IL-4Rα-deficient donor cells or recipient mice demonstrated that IL-4 effects on the host, rather than, or in addition to IL-4 effects on donor cells, were critical for suppression of CTL. Because IL-4 decreased all splenic dendritic cell populations and increased neutrophil and CD8+ T cells, IL-4 may suppress donor CD8+ CTL by decreasing Ag presentation and/or increasing host myeloid and CD8+ T cell suppression of donor T cells. Published by Elsevier Inc.

Entities:  

Keywords:  CTL; Cytokine; Graft-vs.-host disease; IL-4; Mouse; T cells

Mesh:

Substances:

Year:  2017        PMID: 28359782      PMCID: PMC5484589          DOI: 10.1016/j.clim.2017.03.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  26 in total

1.  Development of an assay to measure in vivo cytokine production in the mouse.

Authors:  F D Finkelman; S C Morris
Journal:  Int Immunol       Date:  1999-11       Impact factor: 4.823

2.  Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes.

Authors:  F D Finkelman; K B Madden; S C Morris; J M Holmes; N Boiani; I M Katona; C R Maliszewski
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

3.  Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism.

Authors:  Dennis B Leveson-Gower; Janelle A Olson; Emanuela I Sega; Richard H Luong; Jeanette Baker; Robert Zeiser; Robert S Negrin
Journal:  Blood       Date:  2011-01-21       Impact factor: 22.113

4.  Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease.

Authors:  Roman Puliaev; Phuong Nguyen; Fred D Finkelman; Charles S Via
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

5.  In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.

Authors:  Kateryna Soloviova; Maksym Puliaiev; Mark Haas; Charles S Via
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

Review 6.  Immunological functions of macrophages and their regulation by interferons.

Authors:  J L Virelizier; F Arenzana-Seisdedos
Journal:  Med Biol       Date:  1985

7.  IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.

Authors:  C S Via; V Rus; M K Gately; F D Finkelman
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

8.  Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.

Authors:  A Shustov; P Nguyen; F Finkelman; K B Elkon; C S Via
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

9.  Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.

Authors:  Jason E Foley; Jacopo Mariotti; Kaitlyn Ryan; Michael Eckhaus; Daniel H Fowler
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

10.  Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation.

Authors:  Suzanne C Morris; Stephanie M Heidorn; De'Broski R Herbert; Charles Perkins; David A Hildeman; Marat V Khodoun; Fred D Finkelman
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

View more
  2 in total

1.  Selection of PD1/PD-L1 X-Aptamers.

Authors:  Hongyu Wang; Curtis H Lam; Xin Li; Derek L West; Xianbin Yang
Journal:  Biochimie       Date:  2017-09-11       Impact factor: 4.079

2.  Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer.

Authors:  Kyoko Yamaguchi; Mamoru Ito; Hirofumi Ohmura; Fumiyasu Hanamura; Michitaka Nakano; Kenji Tsuchihashi; Shuntaro Nagai; Hiroshi Ariyama; Hitoshi Kusaba; Hidetaka Yamamoto; Yoshinao Oda; Masafumi Nakamura; Koichi Akashi; Eishi Baba
Journal:  Oncoimmunology       Date:  2020-02-17       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.